DrugPatentWatch Database Preview
Biologic Drugs With Dosage Form: VIAL; SUBCUTANEOUS
» See Plans and Pricing
Details for Dosage Type: VIAL; SUBCUTANEOUS
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | Pathologica LLC (San Francisco, CA) | 2033-01-08 | RX | Orphan | search |
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | 2032-04-02 | RX | Orphan | search | |
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | UBE INDUSTRIES, LTD. (Yamaguchi, JP) | 2036-04-28 | RX | Orphan | search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |